These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 29415808)
1. Procedural Outcome and Midterm Survival of Lower Risk Transfemoral Transcatheter Aortic Valve Implantation Patients Treated With the SAPIEN XT or SAPIEN 3 Device. Vendrik J; van Kesteren F; van Mourik MS; Piek JJ; Tijssen JG; Henriques JPS; Wykrzykowska JJ; de Winter RJ; Driessen AHG; Kaya A; Vis MM; Koch KT; Baan J Am J Cardiol; 2018 Apr; 121(7):856-861. PubMed ID: 29415808 [TBL] [Abstract][Full Text] [Related]
2. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis. Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of transfemoral balloon expandable transcatheter aortic valve implantation: Comparison of two subsequent valve generations. Schymik G; Wendler O; Hengstenberg C; Ohlmann P; Gilard M; Digne F; Souteyrand G; Letocart V; van Belle E; Bramlage P; Tarantini G; Catheter Cardiovasc Interv; 2020 Oct; 96(4):930-939. PubMed ID: 31794159 [TBL] [Abstract][Full Text] [Related]
4. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort. Schulz E; Jabs A; Tamm A; Herz P; Schulz A; Gori T; von Bardeleben S; Kasper-König W; Hink U; Vahl CF; Münzel T Int J Cardiol; 2017 Apr; 232():186-191. PubMed ID: 28089455 [TBL] [Abstract][Full Text] [Related]
6. Comparison of 1-Year Survival and Frequency of Paravalvular Leakage Using the Sapien 3 Versus the Sapien XT for Transcatheter Aortic Valve Implantation for Aortic Stenosis. Meyer A; Unbehaun A; Hamandi M; Sündermann SH; Buz S; Klein C; Stamm C; Falk V; Kempfert J Am J Cardiol; 2017 Dec; 120(12):2247-2255. PubMed ID: 29103606 [TBL] [Abstract][Full Text] [Related]
7. Procedural Results and Clinical Outcomes of Transcatheter Aortic Valve Implantation in Switzerland: An Observational Cohort Study of Sapien 3 Versus Sapien XT Transcatheter Heart Valves. Binder RK; Stortecky S; Heg D; Tueller D; Jeger R; Toggweiler S; Pedrazzini G; Amann FW; Ferrari E; Noble S; Nietlispach F; Maisano F; Räber L; Roffi M; Grünenfelder J; Jüni P; Huber C; Windecker S; Wenaweser P Circ Cardiovasc Interv; 2015 Oct; 8(10):. PubMed ID: 26453687 [TBL] [Abstract][Full Text] [Related]
8. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve. Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408 [TBL] [Abstract][Full Text] [Related]
9. Clinical and procedural outcomes with the SAPIEN 3 versus the SAPIEN XT prosthetic valves in transcatheter aortic valve replacement: A systematic review and meta-analysis. Tummala R; Banerjee K; Sankaramangalam K; Mick S; Krishnaswamy A; White J; Fares M; Mehta A; Popovic Z; Svensson LG; Kapadia SR Catheter Cardiovasc Interv; 2018 Sep; 92(3):E149-E158. PubMed ID: 29068137 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of three different new generation transcatheter aortic valve prostheses. Costa G; Buccheri S; Barbanti M; Picci A; Todaro D; Di Simone E; La Spina K; D'Arrigo P; Criscione E; Nastasi M; Sgroi C; Tamburino C Catheter Cardiovasc Interv; 2020 Feb; 95(3):398-407. PubMed ID: 31609073 [TBL] [Abstract][Full Text] [Related]
11. The balloon-expandable Edwards Sapien 3 valve is superior to the self-expanding Medtronic CoreValve in patients with severe aortic stenosis undergoing transfemoral aortic valve implantation. Gonska B; Seeger J; Baarts J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J J Cardiol; 2017 Jun; 69(6):877-882. PubMed ID: 27614379 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Edwards SAPIEN 3 versus SAPIEN XT in transfemoral transcatheter aortic valve implantation: Difference of valve selection in the real world. Arai T; Lefèvre T; Hovasse T; Morice MC; Garot P; Benamer H; Unterseeh T; Hayashida K; Watanabe Y; Bouvier E; Cormier B; Chevalier B J Cardiol; 2017 Mar; 69(3):565-569. PubMed ID: 27288330 [TBL] [Abstract][Full Text] [Related]
13. Transaortic transcatheter aortic valve implantation using SAPIEN XT or SAPIEN 3 valves in the ROUTE registry. Romano M; Frank D; Cocchieri R; Jagielak D; Bonaros N; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Arne Rein K; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Bapat V Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):757-764. PubMed ID: 28582580 [TBL] [Abstract][Full Text] [Related]
14. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis. Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207 [TBL] [Abstract][Full Text] [Related]
15. Short term clinical outcomes and analysis of risk factors for pacemaker implantation: a single center experience of self-expandable TAVI valves. Chow SCY; Wong RHL; Cheung GSH; Lee APW; Chui HKL; So KCY; Wu EB J Cardiothorac Surg; 2020 Jul; 15(1):200. PubMed ID: 32727521 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement. Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353 [TBL] [Abstract][Full Text] [Related]
17. Comparison of third generation balloon-expandable Edwards Sapien 3 versus self-expandable Evolut R in transcatheter aortic valve implantation: a meta-analysis. Li YM; Tsauo JY; Liao YB; Zhao ZG; Chen M Ann Palliat Med; 2020 May; 9(3):700-708. PubMed ID: 32312063 [TBL] [Abstract][Full Text] [Related]
18. Sapien 3 versus Sapien XT prosthetic valves in transcatheter aortic valve implantation: A meta-analysis. Ando T; Briasoulis A; Holmes AA; Taub CC; Takagi H; Afonso L Int J Cardiol; 2016 Oct; 220():472-8. PubMed ID: 27390972 [TBL] [Abstract][Full Text] [Related]
19. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery. Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510 [TBL] [Abstract][Full Text] [Related]
20. Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve. Gonska B; Seeger J; Keßler M; von Keil A; Rottbauer W; Wöhrle J Clin Res Cardiol; 2017 Aug; 106(8):590-597. PubMed ID: 28283746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]